PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
PRVL
Delisted
PRVL was delisted on the 21st of January, 2021.
76 hedge funds and large institutions have $302M invested in Prevail Therapeutics Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 11 closing their positions.
Holders
76
Holders Change
+9
Holders Change %
+13.43%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
20
Increased
23
Reduced
18
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$24.6M |
| 2 |
2
HighTower Advisors
Chicago,
Illinois
|
$11.5M |
| 3 |
3
BlackRock
New York
|
$20.4M |
| 4 |
4
Morgan Stanley
New York
|
$6.54M |
| 5 |
5
Bank of America
Charlotte,
North Carolina
|
$4.92M |
